Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × Febuxostat × Clear all

NCT03605212 2021-06-03

FLORET

Phase 1/2 Terminated

30 enrolled 14 charts

Other hematologic neoplasm

Tumor Lysis Syndrome, Hematologic Neoplasms